Intraperitoneal injection of synthetic bacterial lipopeptides does not cause a rise in circulating inflammatory cytokines

FEMS Immunol Med Microbiol. 1994 Jan;8(1):77-82. doi: 10.1111/j.1574-695X.1994.tb00428.x.

Abstract

The production of TNF-alpha, IL-1 and IL-6 was measured in mice after i.p. injections of the synthetic bacterial lipopeptide Pam3Cys-Ala-Gly, a potent macrophage and B cell activator in vitro. Only minor amounts of IL-6 and no TNF-alpha were detectable in the serum of mice injected with 10 or 100 micrograms of Pam3Cys-Ala-Gly. Lipopeptide concentrations up to 1000 micrograms failed to induce IL-1, and TNF-alpha production and serum IL-6 levels were only slightly elevated. In contrast to Pam3Cys-Ala-Gly, i.p. injections of LPS were accompanied by high levels of the inflammatory cytokines TNF-alpha, IL-1 and IL-6 suggesting fundamental differences of the mode of action of these two substances when applied in vivo.

Publication types

  • Comparative Study

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Injections, Intraperitoneal
  • Interleukin-1 / biosynthesis
  • Interleukin-1 / blood*
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / blood*
  • Lipopolysaccharides / pharmacology
  • Lipoproteins / administration & dosage
  • Lipoproteins / chemical synthesis
  • Lipoproteins / pharmacology*
  • Mice
  • Molecular Sequence Data
  • Tumor Necrosis Factor-alpha / analysis*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Interleukin-1
  • Interleukin-6
  • Lipopolysaccharides
  • Lipoproteins
  • Tumor Necrosis Factor-alpha
  • N-palmitoyl-5,6-dipalmitoylcysteinyl-alanyl-glycine